SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-007217
Filing Date
2024-02-27
Accepted
2024-02-27 16:12:56
Documents
17
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20240227.htm   iXBRL 8-K 30117
2 EX-99.1 zlab-20240227x8kex991.htm EX-99.1 174579
7 image_1.jpg GRAPHIC 11510
  Complete submission text file 0001628280-24-007217.txt   409199

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20240227.xsd EX-101.SCH 2270
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20240227_def.xml EX-101.DEF 15888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20240227_lab.xml EX-101.LAB 30649
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20240227_pre.xml EX-101.PRE 16626
18 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20240227_htm.xml XML 4062
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 24686857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)